Shuichi Tatarano

Associate professor/MD, PhD

Kagoshima University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Cancer Biology Cancer Biology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Shuichi Tatarano is an Associate Professor at Kagoshima University, Japan. He holds an MD and a PhD, with research interests focusing on renal cell carcinoma, bladder cancer, and prostate cancer. His recent articles explore topics such as the efficacy of cabozantinib and immune checkpoint inhibitors, therapeutic targets in bladder cancer, and glucose tolerance post-kidney transplant.

Articles (14)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (4)

Hirofumi Yoshino

JAPAN

View details

Hiroaki Kobayashi

JAPAN

View details

Masaki Shiota

Kyushu University

JAPAN

View details

Seiya Yokoyama

Assistant Professor

Kagoshima University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Shuichi Tatarano

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Targeting Heat Shock Transcription Factor 4 Enhances the Efficacy of Cabozantinib and Immune Checkpoint Inhibitors in Renal Cell Carcinoma

Segmental Renal Infarction Associated with Accessory Renal Arteries After Para-Aortic Lymphadenectomy in Gynecologic Malignancies

LncRNA BCYRN1 as a Potential Therapeutic Target and Diagnostic Marker in Serum Exosomes in Bladder Cancer

Genome-wide association studies in advanced prostate cancer: KYUCOG-1401-A study

Low dose tacrolimus exposure and early steroid withdrawal with strict body weight control can improve post kidney transplant glucose tolerance in Japanese patients

Randomized controlled trial of GnRH antagonist monotherapy versus GnRH agonist plus bicalutamide (CAB) for patients with metastatic hormone-sensitive prostate cancer (mHSPC) (KYUCOG-1401)

microRNA-99a-5p induces cellular senescence in gemcitabine-resistant bladder cancer by targeting SMARCD1

Laparoscopic Surgery for Pheochromocytoma in Hemodialysis Patients

Exosomal microRNA-1 and MYO15A as a target for therapy and diagnosis in renal cell carcinoma

EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer

Impact of the objective response to and number of cycles of platinum-based first-line chemotherapy for metastatic urothelial carcinoma on overall survival of patients treated with pembrolizumab

Pembrolizumab for treating advanced urothelial carcinoma in patients with impaired performance status: Analysis of a Japanese nationwide cohort

Significance of preoperative screening of deep vein thrombosis and its indications for patients undergoing urological surgery

Significance of preoperative screening of deep vein thrombosis and its indications for patients undergoing urological surgery

Collaborators (4)

Hirofumi Yoshino

Hiroaki Kobayashi

Masaki Shiota

Seiya Yokoyama

Make your next move.